Anson Funds Management LP bought a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 307,000 shares of the company's stock, valued at approximately $3,641,000. Anson Funds Management LP owned approximately 0.11% of Core Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also made changes to their positions in the company. Rise Advisors LLC increased its position in Core Scientific by 14.3% during the third quarter. Rise Advisors LLC now owns 8,000 shares of the company's stock worth $95,000 after buying an additional 1,000 shares during the period. Banque Cantonale Vaudoise acquired a new stake in Core Scientific during the 2nd quarter worth $28,000. Sunbelt Securities Inc. purchased a new position in Core Scientific during the 2nd quarter worth $33,000. Vontobel Holding Ltd. increased its stake in Core Scientific by 10.4% in the third quarter. Vontobel Holding Ltd. now owns 38,089 shares of the company's stock valued at $452,000 after purchasing an additional 3,591 shares during the period. Finally, Harvest Portfolios Group Inc. raised its holdings in shares of Core Scientific by 10.1% in the third quarter. Harvest Portfolios Group Inc. now owns 55,881 shares of the company's stock valued at $663,000 after buying an additional 5,109 shares during the last quarter.
Core Scientific Stock Up 0.3 %
Shares of CORZ traded up $0.05 during mid-day trading on Friday, reaching $16.99. 8,409,119 shares of the company's stock were exchanged, compared to its average volume of 12,078,224. The company has a market cap of $4.74 billion and a price-to-earnings ratio of -3.14. The company has a 50-day simple moving average of $14.70 and a two-hundred day simple moving average of $11.37. Core Scientific, Inc. has a 52-week low of $2.61 and a 52-week high of $18.63.
Insiders Place Their Bets
In related news, Director Yadin Rozov sold 105,000 shares of the business's stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $18.11, for a total value of $1,901,550.00. Following the completion of the sale, the director now directly owns 345,239 shares of the company's stock, valued at $6,252,278.29. The trade was a 23.32 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Todd M. Duchene sold 25,000 shares of the stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $17.10, for a total value of $427,500.00. Following the transaction, the insider now directly owns 1,661,474 shares in the company, valued at approximately $28,411,205.40. This represents a 1.48 % decrease in their position. The disclosure for this sale can be found here. 32.00% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on CORZ shares. HC Wainwright boosted their price target on Core Scientific from $15.00 to $17.00 and gave the company a "buy" rating in a research report on Thursday, November 7th. Canaccord Genuity Group assumed coverage on Core Scientific in a report on Monday, September 23rd. They issued a "buy" rating and a $16.00 target price on the stock. B. Riley increased their price target on Core Scientific from $16.00 to $17.00 and gave the stock a "buy" rating in a report on Thursday, November 7th. Sanford C. Bernstein reiterated an "outperform" rating and issued a $17.00 price objective on shares of Core Scientific in a research report on Tuesday, September 10th. Finally, Needham & Company LLC raised their target price on shares of Core Scientific from $17.00 to $18.00 and gave the stock a "buy" rating in a research note on Thursday, November 7th. Thirteen investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Core Scientific currently has an average rating of "Buy" and an average price target of $18.38.
Read Our Latest Analysis on CORZ
Core Scientific Profile
(
Free Report)
Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.
Read More
Before you consider Core Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.
While Core Scientific currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.